Genesis Innovation Group

Genesis is a technology driven firm, focused on the orthopedic space. Rather than focusing on a particular technology, Genesis is driven by the creation of value by identifying and understanding gaps in the orthopedic marketplace that provide opportunities where new technologies can improve the circumstances for all stakeholders in the care stream. With the belief that success depends on partnerships built on transparency and humility, Genesis is built on partnerships between accomplished and sucessful surgeons, commercial entities, and engineers. Genesis is more than an R&D consulting firm. It's strategy most commonly includes a deep engagement (and self financing) which drives partnerships toward shared objectives, creating an ideal win/win relationship.

R. Sean Churchill

Executive Director

9 past transactions

Embody

Series C in 2022
Embody, Inc. is a regenerative medicine company based in Norfolk, Virginia, dedicated to developing and commercializing implantable medical devices aimed at soft tissue restoration and regeneration. Founded in 2014, the company specializes in biomaterial design and bio-fabrication, focusing on collagen-based microfibers for tendon and ligament repair. Its innovative products are designed to meet the needs of warfighters, athletes, and individuals with sports injuries, utilizing a precision medicine approach to replicate the biological and biomechanical properties of native tissue. The goal of Embody is to enhance the quality of life for patients by restoring their pre-injury performance through effective healing solutions.

HAPPE Spine

Venture Round in 2021
HAPPE Spine LLC is a healthcare company based in Grand Rapids, Michigan, focused on developing and commercializing innovative material technologies for spinal implants. Incorporated in 2018, the company specializes in creating partial and fully porous hydroxyapatite reinforced polyetheretherketone (PEEK) implants. HAPPE Spine's technology enhances the mechanical properties of PEEK materials, providing improved surface textures that promote bone engagement and interconnected porosity for long-term fixation. Additionally, the bioactive properties of their implants support effective bone in-growth and on-growth, addressing various orthopedic challenges. HAPPE Spine operates as a subsidiary of Genesis Innovation Group, LLC.

Virtual Incision

Series B in 2020
Virtual Incision is focused on developing innovative surgical solutions, specifically through its miniaturized robotic support device designed for colon resection. The company's flagship product, the MIRA (Miniaturized In vivo Robotic Assistant) Platform, is a pioneering device that aims to streamline surgical procedures by allowing for quick setup in the operating room without the need for heavy equipment. This technology is intended to assist surgeons in improving clinical outcomes while also addressing healthcare costs. Virtual Incision's approach represents a significant advancement in robotic-assisted surgery, with plans for future applications beyond colon resection.

Embody

Venture Round in 2019
Embody, Inc. is a regenerative medicine company based in Norfolk, Virginia, dedicated to developing and commercializing implantable medical devices aimed at soft tissue restoration and regeneration. Founded in 2014, the company specializes in biomaterial design and bio-fabrication, focusing on collagen-based microfibers for tendon and ligament repair. Its innovative products are designed to meet the needs of warfighters, athletes, and individuals with sports injuries, utilizing a precision medicine approach to replicate the biological and biomechanical properties of native tissue. The goal of Embody is to enhance the quality of life for patients by restoring their pre-injury performance through effective healing solutions.

Shoulder Innovations

Series A in 2018
Shoulder Innovations is a medical device company that has developed inset glenoid fixation technology, creating the most robust and stable glenoid platform in the industry. The company's Total Shoulder Replacement System addresses the most significant issue in shoulder arthroplasty: unreliable fixation of the glenoid implant. It also leverages this technology to create simple surgical instrumentation, which reduces operative time and cost. Shoulder Innovations designs and commercializes innovative products that demonstrate the potential for improved patient care and reduced overall cost to the healthcare system. Published results show Shoulder Innovations’ solution provides greater post-surgical implant stability, addressing the leading cause of revision surgery.

HAPPE Spine

Seed Round in 2018
HAPPE Spine LLC is a healthcare company based in Grand Rapids, Michigan, focused on developing and commercializing innovative material technologies for spinal implants. Incorporated in 2018, the company specializes in creating partial and fully porous hydroxyapatite reinforced polyetheretherketone (PEEK) implants. HAPPE Spine's technology enhances the mechanical properties of PEEK materials, providing improved surface textures that promote bone engagement and interconnected porosity for long-term fixation. Additionally, the bioactive properties of their implants support effective bone in-growth and on-growth, addressing various orthopedic challenges. HAPPE Spine operates as a subsidiary of Genesis Innovation Group, LLC.

SafKan, Inc.

Seed Round in 2018
SafKan, Inc. is a medical device company based in Tucson, Arizona, focused on developing and manufacturing automated ear cleaning solutions for clinical applications. Founded in 2016, the company offers the OtoSet, an FDA-cleared and wearable device designed to facilitate mess-free earwax removal. With approximately 35 million Americans affected by impacted earwax, which can lead to conductive hearing loss, the OtoSet provides a safe and effective method for addressing mild to severe earwax impactions. The device employs hygienic disposable ear tips and waste containers, allowing for both bilateral and unilateral procedures, enhancing patient comfort and ensuring a streamlined process for healthcare providers.

Shoulder Innovations

Series A in 2017
Shoulder Innovations is a medical device company that has developed inset glenoid fixation technology, creating the most robust and stable glenoid platform in the industry. The company's Total Shoulder Replacement System addresses the most significant issue in shoulder arthroplasty: unreliable fixation of the glenoid implant. It also leverages this technology to create simple surgical instrumentation, which reduces operative time and cost. Shoulder Innovations designs and commercializes innovative products that demonstrate the potential for improved patient care and reduced overall cost to the healthcare system. Published results show Shoulder Innovations’ solution provides greater post-surgical implant stability, addressing the leading cause of revision surgery.

Magnesium Development

Seed Round in 2016
Magnesim Development Company, LLC (MDC) is a medical device development company delivering devices of a breakthrough resorbable metal alloy technology combining the strength and handling properties of metal with complete absorption for application in sports medicine orthopedics. Why is this important? Existing materials available for surgical repair marginally meet current surgical demands. Unsolved problems remain (delayed or lack of resorption, loose bodies, cyst formation, mechanical failure, post-operative imaging, etc) in surgical repair of soft tissue injuries (including knee, shoulder, and lower extremities). Occurrence of soft tissue, sports injury related medical events continue to grow as patients remain active longer, and expectations for return to activity increase. With more natural absorption, there remains potential for a bone growth stimulative effect, further enabling the return to activity and lifestyle.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.